Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
TREATMENT OF ADVANCED MYELODYSPLASTIC SYNDROME WITH ALFACALCIDOL
GENOMIC ALTERATIONS INVOLVING THE C-MYC PROTO-ONCOGENE LOCUS DURING THE EVOLUTION OF A CASE OF CHRONIC GRANULOCYTIC LEUKAEMIA
- D. Mccarthy, J. Goldman, F. Rassool, S. Graham, G. Birnie
- Medicine, Biology
- The Lancet
- 15 December 1984
New clones of cells that proliferate during the evolution of a myeloid leukaemia can carry genetic changes in addition to any recognisable karyotypic changes, which might underlie the progression of the disease. Expand
Low-dose beta blockade in the treatment of chronic cardiac failure.
THALIDOMIDH FOR GRAFT-VERSUS-HOST DISEASE
Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia
Thalidomide for graft-versus-host disease.
1,25-DIHYDROXYVITAMIN D3 AND MYELOFIBROSIS
STEROIDS FOR PNEUMONITIS AFTER BONE-MARROW TRANSPLANTATION
PROGNOSTIC SIGNIFICANCE OF SERUM-LYSOZYME IN A.M.L.